Autophagy and necroptosis in cisplatin-induced acute kidney injury: Recent advances regarding their role and therapeutic potential
Cisplatin (CP) is a broad-spectrum antineoplastic agent, used to treat many different types of malignancies due to its high efficacy and low cost. However, its use is largely limited by acute kidney injury (AKI), which, if left untreated, may progress to cause irreversible chronic renal dysfunction....
Main Authors: | Noha Alassaf, Hala Attia |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1103062/full |
Similar Items
-
Dynamics of necroptosis in kidney ischemia-reperfusion injury
by: Aspasia Pefanis, et al.
Published: (2023-11-01) -
AMPK/mTOR Signaling in Autophagy Regulation During Cisplatin-Induced Acute Kidney Injury
by: Ying Wang, et al.
Published: (2020-12-01) -
Melatonin Attenuates Cisplatin-Induced Acute Kidney Injury through Dual Suppression of Apoptosis and Necroptosis
by: Jong Woo Kim, et al.
Published: (2019-08-01) -
Comment on: A model for prediction of cisplatin induced nephrotoxicity by kidney weight in experimental rats
by: Hamid Nasri
Published: (2013-01-01) -
Autophagy in Cisplatin Nephrotoxicity during Cancer Therapy
by: Xiaoru Hu, et al.
Published: (2021-11-01)